lobbying_activities: 1376808

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1376808	52119da8-98f1-48b9-8831-f8b16482d970	Q1	RED+BLUE STRATEGIES	400693064	PEW CHARITABLE TRUSTS	2013	first_quarter	PHA	Issues related to continuing to increase the supply of new and innovative antibiotics that will help to treat the myriad antibiotic resistant strains of bugs like MRSA.H.R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - Focused on funding for the FDA, CDC and other public health related industries. H.R. 307 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 - Focus on the potential for language that would allow for greater focus on the need for new antibiotics to enter into the pipeline. Continued work on issues related to downstream supply chain safety of prescription medications Issues related to safety in compounding of certain medications	Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2013-04-18T11:57:52.613000-04:00